Pharmaceutical composition using endogenous cells for preventing or treating musculoskeletal disorders
AssigneeSeoul National University R&Db Foundation
InventorsHyun Chul Jo, Seung Yeon Lee
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to a pharmaceutical composition for preventing or treating musculoskeletal disease, which has the effect of proliferating endogenous cells in bone marrow. More specifically, the pharmaceutical composition of the present disclosure can be used for the treatment of musculoskeletal disease since it proliferates endogenous cells in bone marrow and enhances the functions thereof.
Claims12
A method for increasing proliferation of endogenous stem cells for regenerating torn or ruptured connective tissue, comprising the step of administering a therapeutically effective amount of a pharmaceutical composition to a human or a rat, wherein the pharmaceutical composition comprises platelet-rich plasma (PRP), batroxobin, calcium and tranexamic acid as active ingredients, and
- wherein the pharmaceutical composition is administered intraosseously.
A method for increasing proliferation of endogenous stem cells for regenerating torn or ruptured connective tissue, comprising the step of administering a therapeutically effective amount of a pharmaceutical composition to a human, wherein the pharmaceutical composition comprises platelet-rich plasma (PRP), batroxobin, calcium and tranexamic acid as active ingredients, and
- wherein the pharmaceutical composition is administered intraosseously.
Dependencies are inferred from the claim text.